Scholars Central

Research articlePublished 13 Jul 2017

The Cytotoxic evaluation of fluvastatin and rosuvastatin and effect of fluvastatin in the hela cell cycle.

Authors: María Campos-Lara, José Alberto Mendoza-Espinoza

International Journal of Pharmacy and Pharmacology

Volume 6 · Issue 10 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, were originally designed to reduce cholesterol biosynthesis and have been extensively used as prevention drugs against hyperlipidemia and cardiovascular conditions. Recently, these compounds have been shown to display chemopreventive activity against cancer. However, the effects of statins on cancer are not completely understood. For this reason, we have studied the cytotoxic effect of rosuvastatin and fluvastatin on three cell tumoral lines: human larynx carcinoma (HEp- 2), human nasopharyngeal carcinoma (KB), and human epithelial carcinoma (HeLa). We have found that only fluvastatin has relevant activity against the tumoral cell lines assayed and the capacity to arrest G1- phase, whereas a significant decline was observed in the S-phase percentage. Fluvastatin IC50 were 2.43±0.56 g/mL (HEp-2), 2.29±0.19 g/mL (KB), and 5.02±1.52 g/mL (HeLa), whereas rosuvastatin showed poor activity. These results indicate that the cytotoxic effect of fluvastatin may not depend directly on HMG-CoA reductase inhibition. The antitumor statins effect needs further investigation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Pharmacy and Pharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Pharmacy and Pharmacology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “María Campos-Lara”
  • BylineArticles whose byline prints “José Alberto Mendoza-Espinoza”